US Patent Issued to Pacira Pharmaceuticals on Oct. 7 for "Uses of bupivacaine multivesicular liposomes as stellate ganglion block" (Florida, Maryland Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,878, issued on Oct. 7, was assigned to Pacira Pharmaceuticals Inc. (San Diego).

"Uses of bupivacaine multivesicular liposomes as stellate ganglion block" was invented by Roy Winston (Tampa, Fla.), Jared Ham (Severn, Md.) and Jonathan Slonin (Palm City, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments of the present disclosure relate to the use of bupivacaine multivesicular liposomes (MVLs) as stellate ganglion block (SGB) for treating or ameliorating various diseases and conditions, including but not limited to cardiac electrical storm or cardiac arrythmia/dysrhythmia following heart surgery."

The patent was filed on Feb. 21, 2023, un...